ALVESCO 200 MCG
CICLESONIDE : 200 MCG · DIN 02285614 · COVIS PHARMA GMBH
Health Canada status: MARKETED
What is ALVESCO?
ALVESCO 200 MCG contains CICLESONIDE : 200 MCG. It is listed in the Health Canada Drug Product Database under DIN 02285614, held by COVIS PHARMA GMBH, supplied as AEROSOL, METERED DOSE for INHALATION administration. Health Canada currently lists it as marketed, status dated 10-Feb-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ALVESCO used for?
Prophylactic management of steroid-responsive bronchial asthma in adults, adolescents and children 6 years of age and older. Not for acute attacks.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02285614 |
|---|---|
| Brand name | ALVESCO |
| Generic / active ingredient | CICLESONIDE : 200 MCG |
| Manufacturer | COVIS PHARMA GMBH |
| Strength | 200 MCG |
| Dosage form | AEROSOL, METERED DOSE |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03BA08 CICLESONIDE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 10-Feb-2021 |
| Original market date | 2006-09-27 00:00:00 |
How is it administered?
Adults/Adolescents (12+): 100-800 mcg/day (starting 400 mcg once daily). Children (6-11): 100-200 mcg once daily. Titrate to lowest effective dose. Administer via oral inhalation.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in the provided text snippet (Table of Contents lists page 18, but text ends before page 18).
How is it supplied?
Metered dose inhaler (ex-valve delivery). Specific pack sizes not listed in provided text.
Contraindications
Hypersensitivity to ingredients; untreated fungal, bacterial or tuberculosis respiratory infections; primary treatment of status asthmaticus or acute asthma; moderate to severe bronchiectasis.
Warnings and precautions
Not for acute attacks. Risk of adrenal insufficiency when transferring from oral steroids. Potential systemic effects: growth retardation, decreased bone density, cataracts, and glaucoma.
What can be used instead?
Other Canadian products sharing ATC code R03BA08 CICLESONIDE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALVESCO | 100 MCG | AEROSOL, METERED DOSE | COVIS PHARMA GMBH | MARKETED | DIN 02285606 |
| ALVESCO | 50 MCG | AEROSOL, METERED DOSE | TAKEDA CANADA INC | CANCELLED PRE MARKET | DIN 02285592 |
Who else supplies CICLESONIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CICLESONIDE appears in 36 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.